Title Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients

[1]  K. Nakao,et al.  An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions , 2015, Clinical and Experimental Nephrology.

[2]  D. Bernlohr,et al.  Lipocalin 2 Expression and Secretion Is Highly Regulated by Metabolic Stress, Cytokines, and Nutrients in Adipocytes , 2014, PloS one.

[3]  Y. Hasuike,et al.  Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? , 2012, Clinical and Experimental Nephrology.

[4]  Shi-Xian Deng,et al.  The Ngal Reporter Mouse Detects the Response of the Kidney to Injury in Real Time , 2010, Nature Medicine.

[5]  J. Zha,et al.  Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival , 2010, BMC nephrology.

[6]  R. Strong,et al.  Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex , 2010, Nature chemical biology.

[7]  R. Zager,et al.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury. , 2010, American journal of physiology. Renal physiology.

[8]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. , 2010, Cancer letters.

[9]  J. Małyszko,et al.  Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation , 2010, Kidney and Blood Pressure Research.

[10]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Tak W. Mak,et al.  Lipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection 1 , 2009, The Journal of Immunology.

[12]  B. Molitoris,et al.  Ironing out the pathogenesis of acute kidney injury. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Rinaldo Bellomo,et al.  Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery—A prospective cohort study* , 2009, Critical care medicine.

[14]  D. Bolignano,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[15]  桑原 孝成 Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons , 2009 .

[16]  Shizuo Akira,et al.  Lipocalin 2-Dependent Inhibition of Mycobacterial Growth in Alveolar Epithelium1 , 2008, The Journal of Immunology.

[17]  Manuela M. Santos,et al.  Anemia upregulates lipocalin 2 in the liver and serum. , 2008, Blood cells, molecules & diseases.

[18]  D. Bolignano,et al.  Neutrophil Gelatinase-Associated Lipocalin Reflects the Severity of Renal Impairment in Subjects Affected by Chronic Kidney Disease , 2008, Kidney and Blood Pressure Research.

[19]  D. Bernlohr,et al.  The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. , 2008, Molecular endocrinology.

[20]  Kohsuke Yamada,et al.  Simplified nutritional screening tools for patients on maintenance hemodialysis. , 2008, The American journal of clinical nutrition.

[21]  M. Mitsnefes,et al.  Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study , 2007, Critical care.

[22]  N. Houstis,et al.  The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance , 2007, Diabetes.

[23]  Y. Hsu,et al.  Neutrophils in acidotic haemodialysed patients have lower intracellular pH and inflamed state. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  K. Nakao,et al.  Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. , 2007, Kidney international.

[25]  E. Kraegen,et al.  Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. , 2007, Clinical chemistry.

[26]  S. Goldstein,et al.  Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[27]  Mihwa Kim,et al.  Association between Increases in Urinary Neutrophil Gelatinase–associated Lipocalin and Acute Renal Dysfunction after Adult Cardiac Surgery , 2006, Anesthesiology.

[28]  H. Umehara,et al.  Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. , 2006, Blood.

[29]  Satoshi Okayama,et al.  Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[30]  J. Cowland,et al.  IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. , 2006, Journal of immunology.

[31]  P. Moseley,et al.  Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease. , 2005, Kidney international.

[32]  Ioannis Nicolis,et al.  Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. , 2005, The American journal of clinical nutrition.

[33]  V. Sukhatme,et al.  Lipocalin 2 Diminishes Invasiveness and Metastasis of Ras-transformed Cells* , 2005, Journal of Biological Chemistry.

[34]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[35]  Ian R. Drexler,et al.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. , 2005, The Journal of clinical investigation.

[36]  K. Mori,et al.  Cell biology: Iron thievery , 2004, Nature.

[37]  Shizuo Akira,et al.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.

[38]  K. Kalantar-Zadeh,et al.  POOR NUTRITIONAL STATUS AND INFLAMMATION: Metabolic Acidosis and Malnutrition‐Inflammation Complex Syndrome in Chronic Renal Failure , 2004, Seminars in dialysis.

[39]  Hubertus Haas,et al.  Human Tear Lipocalin Exhibits Antimicrobial Activity by Scavenging Microbial Siderophores , 2004, Antimicrobial Agents and Chemotherapy.

[40]  K. Kalantar-Zadeh,et al.  57 A LOW, RATHER THAN A HIGH, TOTAL PLASMA HOMOCYSTEINE IS AN INDICATOR OF POOR OUTCOME IN HEMODIALYSIS PATIENTS. , 2004, Journal of Investigative Medicine.

[41]  Matthias W. Hentze,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004 .

[42]  K. Kalantar-Zadeh,et al.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.

[43]  H. Erdjument-Bromage,et al.  An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.

[44]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[45]  W. Hörl Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. , 2002, Journal of the American Society of Nephrology : JASN.

[46]  J. Bower,et al.  Risk Factor Paradox in Hemodialysis: Better Nutrition as a Partial Explanation , 2001, ASAIO journal.

[47]  F. Dumler,et al.  Impact of dialysis modality and acidosis on nutritional status. , 1999, ASAIO journal.

[48]  S. Nakai,et al.  New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations. , 2008, Artificial organs.

[49]  J. Bergström Nutrition and mortality in hemodialysis. , 1995, Journal of the American Society of Nephrology : JASN.

[50]  P. Venge,et al.  Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. , 1995, Scandinavian journal of clinical and laboratory investigation.

[51]  S. Nakai,et al.  Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. , 1994, Nephron.

[52]  J. Daugirdas Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. , 1993, Journal of the American Society of Nephrology : JASN.

[53]  H. Sengeløv,et al.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. , 1993, The Journal of biological chemistry.

[54]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  O. Lockridge,et al.  Complete amino acid sequence of human serum cholinesterase. , 1987, The Journal of biological chemistry.

[56]  R. Chandra NUTRITION, IMMUNITY, AND INFECTION: PRESENT KNOWLEDGE AND FUTURE DIRECTIONS , 1983, The Lancet.

[57]  S B Heymsfield,et al.  Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. , 1983, The American journal of clinical nutrition.

[58]  F. Gotch,et al.  Nitrogen balance during intermittent dialysis therapy of uremia. , 1978, Kidney international.

[59]  A. Dalmasso,et al.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. , 1977, The Journal of clinical investigation.

[60]  Eisenberg,et al.  Interpretation of Serum Calcium in Patients with Abnormal Serum Proteins , 1973, British medical journal.

[61]  E. Drenick,et al.  Neutropenia in prolonged fasting. , 1971, The American journal of clinical nutrition.